Amgen Operating Income 2006-2020 | AMGN

Amgen annual/quarterly operating income history and growth rate from 2006 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Amgen operating income for the quarter ending June 30, 2020 was $2.323B, a 13.26% decline year-over-year.
  • Amgen operating income for the twelve months ending June 30, 2020 was $9.202B, a 6.63% decline year-over-year.
  • Amgen annual operating income for 2019 was $9.674B, a 5.74% decline from 2018.
  • Amgen annual operating income for 2018 was $10.263B, a 2.91% increase from 2017.
  • Amgen annual operating income for 2017 was $9.973B, a 1.83% increase from 2016.
Amgen Annual Operating Income
(Millions of US $)
2019 $9,674
2018 $10,263
2017 $9,973
2016 $9,794
2015 $8,470
2014 $6,191
2013 $5,867
2012 $5,577
2011 $4,312
2010 $5,545
2009 $5,506
2008 $5,214
2007 $3,980
2006 $3,840
2005 $4,848
Amgen Quarterly Operating Income
(Millions of US $)
2020-06-30 $2,323
2020-03-31 $2,355
2019-12-31 $2,048
2019-09-30 $2,476
2019-06-30 $2,678
2019-03-31 $2,472
2018-12-31 $2,382
2018-09-30 $2,323
2018-06-30 $2,832
2018-03-31 $2,726
2017-12-31 $2,245
2017-09-30 $2,439
2017-06-30 $2,698
2017-03-31 $2,591
2016-12-31 $2,485
2016-09-30 $2,527
2016-06-30 $2,380
2016-03-31 $2,402
2015-12-31 $2,033
2015-09-30 $2,339
2015-06-30 $2,076
2015-03-31 $2,022
2014-12-31 $1,459
2014-09-30 $1,466
2014-06-30 $1,902
2014-03-31 $1,364
2013-12-31 $1,187
2013-09-30 $1,688
2013-06-30 $1,550
2013-03-31 $1,442
2012-12-31 $1,088
2012-09-30 $1,423
2012-06-30 $1,589
2012-03-31 $1,477
2011-12-31 $1,162
2011-09-30 $525
2011-06-30 $1,332
2011-03-31 $1,293
2010-12-31 $1,068
2010-09-30 $1,479
2010-06-30 $1,517
2010-03-31 $1,481
2009-12-31 $1,123
2009-09-30 $1,605
2009-06-30 $1,457
2009-03-31 $1,321
2008-12-31 $1,137
2008-09-30 $1,483
2008-06-30 $1,179
2008-03-31 $1,415
2007-12-31 $1,057
2007-09-30 $393
2007-06-30 $1,130
2007-03-31 $1,400
2006-12-31 $989
2006-09-30 $1,322
2006-06-30 $295
2006-03-31 $1,234
2005-12-31 $1,101
2005-09-30 $1,298
2005-06-30 $1,293
2005-03-31 $1,156
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $141.574B $23.362B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.998B 11.09
CSL (CSLLY) Australia $92.626B 0.00
Gilead Sciences (GILD) United States $86.306B 12.43
Vertex Pharmaceuticals (VRTX) United States $70.548B 39.37
Regeneron Pharmaceuticals (REGN) United States $67.370B 24.91
Illumina (ILMN) United States $50.589B 58.43
Biogen (BIIB) United States $46.421B 7.94
Seattle Genetics (SGEN) United States $27.629B 0.00
Moderna (MRNA) United States $27.432B 0.00
Genmab (GMAB) Denmark $23.773B 19.56
Alexion Pharmaceuticals (ALXN) United States $22.527B 9.39
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.281B 0.00
Genmab (GNMSF) Denmark $21.968B 65.22
BioMarin Pharmaceutical (BMRN) United States $21.403B 155.29
Incyte (INCY) United States $20.606B 0.00
BeiGene (BGNE) Cayman Islands $19.054B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.852B 0.00
BioNTech SE (BNTX) Germany $15.637B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.061B 68.12
Horizon Therapeutics Public (HZNP) Ireland $14.999B 35.10
Exact Sciences (EXAS) United States $13.087B 0.00
Galapagos (GLPG) Belgium $12.406B 44.95
Sarepta Therapeutics (SRPT) United States $12.404B 0.00
QIAGEN (QGEN) Netherlands $11.028B 27.99
ARGENX SE-ADR (ARGX) Netherlands $10.912B 0.00
Bio-Techne Corp (TECH) United States $10.069B 69.69
Immunomedics (IMMU) United States $9.389B 0.00
Guardant Health (GH) United States $8.626B 0.00
Novavax (NVAX) United States $7.624B 0.00
Repligen (RGEN) United States $7.504B 119.11
Ascendis Pharma (ASND) Denmark $7.451B 0.00
Emergent Biosolutions (EBS) United States $6.857B 27.16
Exelixis (EXEL) United States $6.755B 24.56
Vir Biotechnology (VIR) United States $6.717B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.407B 198.50
SWEDISH ORP BIO (BIOVF) Sweden $6.375B 15.86
ACADIA Pharmaceuticals (ACAD) United States $6.285B 0.00
Mirati Therapeutics (MRTX) United States $5.861B 0.00
Acceleron Pharma (XLRN) United States $5.522B 0.00
MyoKardia (MYOK) United States $5.381B 0.00
Adaptive Biotechnologies (ADPT) United States $5.209B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.078B 0.00
Zai Lab (ZLAB) China $4.628B 0.00
NeoGenomics (NEO) United States $4.413B 1332.00
MorphoSys AG (MOR) Germany $4.282B 56.12
China Biologic Products (CBPO) China $4.175B 23.21
Blueprint Medicines (BPMC) United States $4.100B 0.00
Bluebird Bio (BLUE) United States $4.091B 0.00
Halozyme Therapeutics (HALO) United States $3.913B 0.00
Amicus Therapeutics (FOLD) United States $3.783B 0.00
Global Blood Therapeutics (GBT) United States $3.782B 0.00
Arena Pharmaceuticals (ARNA) United States $3.659B 0.00
Reata Pharmaceuticals (RETA) United States $3.434B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.417B 0.00
Denali Therapeutics (DNLI) United States $3.174B 0.00
Sorrento Therapeutics (SRNE) United States $3.004B 0.00
Insmed (INSM) United States $3.002B 0.00
Fate Therapeutics (FATE) United States $2.962B 0.00
Alkermes (ALKS) Ireland $2.960B 62.03
Principia Biopharma (PRNB) United States $2.900B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.644B 0.00
Amarin (AMRN) Ireland $2.552B 0.00
Twist Bioscience (TWST) United States $2.544B 0.00
Inovio Pharmaceuticals (INO) United States $2.303B 0.00
Editas Medicine (EDIT) United States $2.164B 0.00
Viela Bio (VIE) United States $1.959B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
UniQure (QURE) Netherlands $1.846B 0.00
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 60.74
Seres Therapeutics (MCRB) United States $1.797B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.762B 0.00
I-Mab (IMAB) China $1.675B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
Eidos Therapeutics (EIDX) United States $1.633B 0.00
Revance Therapeutics (RVNC) United States $1.623B 0.00
Cytokineticsorporated (CYTK) United States $1.545B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.466B 0.00
Zealand Pharma (ZEAL) Denmark $1.423B 0.00
Zymeworks (ZYME) Canada $1.382B 0.00
Mesoblast (MESO) Australia $1.379B 0.00
Coherus BioSciences (CHRS) United States $1.351B 7.88
Forma Therapeutics Holdings (FMTX) United States $1.326B 0.00
Intra-Cellular Therapies (ITCI) United States $1.302B 0.00
Epizyme (EPZM) United States $1.293B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
NGM Biopharmaceuticals (NGM) United States $1.261B 0.00
Mersana Therapeutics (MRSN) United States $1.244B 0.00
REGENXBIO (RGNX) United States $1.215B 0.00
Adverum Biotechnologies (ADVM) United States $1.202B 0.00
Compugen (CGEN) Israel $1.201B 0.00
Intellia Therapeutics (NTLA) United States $1.199B 0.00
Akcea Therapeutics (AKCA) United States $1.158B 0.00
Alcobra (ARCT) United States $1.153B 0.00
Beam Therapeutics (BEAM) United States $1.147B 0.00
Arcus Biosciences (RCUS) United States $1.139B 0.00
Arvinas (ARVN) United States $1.084B 0.00
Alector (ALEC) United States $1.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.029B 0.00
NantKwest (NK) United States $1.005B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.976B 0.00
Myriad Genetics (MYGN) United States $0.974B 50.27
Heska (HSKA) United States $0.965B 0.00
Athenex (ATNX) United States $0.949B 0.00
Retrophin (RTRX) United States $0.937B 0.00
Morphic Holding (MORF) United States $0.858B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.838B 0.00
Castle Biosciences (CSTL) United States $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Pharming Group (PHGUF) Netherlands $0.807B 18.43
Cara Therapeutics (CARA) United States $0.798B 0.00
Codexis (CDXS) United States $0.791B 0.00
Dynavax Technologies (DVAX) United States $0.755B 0.00
Intrexon (PGEN) United States $0.748B 0.00
Frequency Therapeutics (FREQ) United States $0.719B 0.00
Cellectis S.A (CLLS) France $0.713B 0.00
Vericel (VCEL) United States $0.711B 0.00
Kadmon Holdings (KDMN) United States $0.710B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.695B 0.00
MiMedx (MDXG) United States $0.686B 0.00
Biofrontera AG (BFRA) Germany $0.684B 0.00
Agenus (AGEN) United States $0.653B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.651B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.650B 5.69
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.614B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.586B 0.00
Syros Pharmaceuticals (SYRS) United States $0.554B 0.00
MeiraGTx Holdings (MGTX) United States $0.532B 0.00
Kala Pharmaceuticals (KALA) United States $0.512B 0.00
Anika Therapeutics (ANIK) United States $0.507B 22.16
Prothena (PRTA) Ireland $0.503B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Innate Pharma S.A (IPHA) France $0.482B 0.00
Cel-Sci (CVM) United States $0.480B 0.00
Protagonist Therapeutics (PTGX) United States $0.467B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.462B 32.68
Aquinox Pharmaceuticals (NLTX) United States $0.460B 0.00
Athersys (ATHX) United States $0.456B 0.00
Avid Bioservices (CDMO) United States $0.455B 0.00
AC Immune SA (ACIU) Switzerland $0.451B 0.00
Pfenex (PFNX) United States $0.442B 0.00
Clovis Oncology (CLVS) United States $0.431B 0.00
Prometic Life Sciences (LMNL) Canada $0.414B 0.00
Scholar Rock Holding (SRRK) United States $0.394B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.394B 0.00
Puma Biotechnology (PBYI) United States $0.394B 0.00
ANI Pharmaceuticals (ANIP) United States $0.390B 9.19
PDL BioPharma (PDLI) United States $0.377B 0.00
Merus (MRUS) Netherlands $0.377B 0.00
Cellular Biomedicine (CBMG) United States $0.374B 0.00
MannKind (MNKD) United States $0.374B 0.00
Albireo Pharma (ALBO) United States $0.367B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.366B 0.00
Kamada (KMDA) Israel $0.358B 17.13
Precision BioSciences (DTIL) United States $0.346B 0.00
WAVE Life Sciences (WVE) Singapore $0.339B 0.00
Geron (GERN) United States $0.333B 0.00
CytomX Therapeutics (CTMX) United States $0.327B 0.00
Trevena (TRVN) United States $0.301B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
ChromaDex (CDXC) United States $0.301B 0.00
IBio (IBIO) United States $0.290B 0.00
Arbutus Biopharma (ABUS) United States $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.284B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
Selecta Biosciences (SELB) United States $0.277B 0.00
Starpharma Holdings (SPHRY) Australia $0.271B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Menlo Therapeutics (MNLO) United States $0.267B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Verastem (VSTM) United States $0.261B 0.00
NextCure (NXTC) United States $0.261B 0.00
Affimed (AFMD) Germany $0.255B 0.00
DBV Technologies S.A (DBVT) France $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.251B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Dyadic (DYAI) United States $0.241B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Northwest Biotherapeutics (NWBO) United States $0.233B 0.00
Celldex Therapeutics (CLDX) United States $0.230B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
Pluristem Therapeutics (PSTI) Israel $0.223B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Sutro Biopharma (STRO) United States $0.207B 0.00
Exicure (XCUR) United States $0.200B 0.00
Aduro Biotech (ADRO) United States $0.200B 0.00
XOMA (XOMA) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.199B 9.30
Nymox Pharmaceutical (NYMX) Canada $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.193B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Cyclerion Therapeutics (CYCN) United States $0.179B 0.00
Aptinyx (APTX) United States $0.176B 0.00
Five Prime Therapeutics (FPRX) United States $0.175B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.170B 0.00
VTv Therapeutics (VTVT) United States $0.169B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
Aytu Bioscience (AYTU) United States $0.158B 0.00
Bellus Health (BLU) Canada $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.155B 0.00
TELA Bio (TELA) United States $0.150B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
VolitionRX (VNRX) United States $0.139B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.137B 0.00
Gritstone Oncology (GRTS) United States $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.129B 0.00
Cardiff Oncology (CRDF) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 6.45
Palatin Technologies (PTN) United States $0.127B 3.25
Lumos Pharma (LUMO) United States $0.125B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
CorMedix Inc (CRMD) United States $0.124B 0.00
Protalix BioTherapeutics (PLX) Israel $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.120B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.118B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.104B 0.00
Antibe Therapeutics (ATBPF) Canada $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.090B 0.00
Organovo Holdings (ONVO) United States $0.090B 0.00
AquaBounty Technologies (AQB) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
AnPac Bio-Medical Science (ANPC) China $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
DiaMedica Therapeutics (DMAC) United States $0.075B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.064B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 90.00
Aerpio Pharmaceuticals (ARPO) United States $0.062B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
Genetic Technologies (GENE) Australia $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Novogen (KZIA) Australia $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Spherix (AIKI) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Chanticleer Holdings (SONN) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00